HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
 Experimental Treatments
 HBV Articles by Topic

HBV Genotypes A, B, C, D, G

Antiviral Therapy May Promote Hepatitis B Virus Genotype Changes - 10/24/2008

Individuals with Hepatitis B Virus Genotype C Experience HBeAg Clearance Later and Less Often - 12/14/07

HBV Genotype and Baseline Viral Load Predict Response to Adefovir (Hepsera) in Lamivudine-resistant Chronic Hepatitis B Patients - 10/12/07

HBV Genotype Influences Drug Resistance and Vaccine Escape  - 3/30/07

Hepatitis B Virus Genotypes and Lamivudine-resistant Mutations in HIV-HBV Coinfected Patients 2/06/07

Differences Between Hepatocellular Carcinoma Related to Hepatitis B Genotypes B and C 1/23/07

Hepatitis B Virus Genotypes Associated with Treatment Response and Disease Progression  12/15/06

Influence of HBV Genotypes on Disease Parameters   10/10/06

Treatment with PegInterferon Alfa-2b: HBsAg Loss Is Associated with HBV Genotype - 2/24/06

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
 Epivir-HBV  (lamivudine; 3TC)
 Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
 Tyzeka   (telbivudine)